Imaging Proliferation of Stage IV Cutaneous Melanoma With 18 F-FLT PET/CT : A Potential Noninvasive Tool for Predicting Treatment Resistance to Targeted Therapy?
- DOI
- 10.1097/rlu.0000000000005999
- Published
- 2025 Aug 1
- Container
- Clinical nuclear medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1097/rlu.0000000000005999,
title = {Imaging Proliferation of Stage IV Cutaneous Melanoma With 18 F-FLT PET/CT : A Potential Noninvasive Tool for Predicting Treatment Resistance to Targeted Therapy?},
author = {van der Hiel B and Vogel WV and van den Eertwegh AJM and Vlahu CA and de Vos FYFL and Boers-Sonderen MJ and Stokkel MPM and Aalbersberg EA and Haanen JBAG},
year = {2025},
journal = {Clinical nuclear medicine},
doi = {10.1097/rlu.0000000000005999},
url = {https://doi.org/10.1097/rlu.0000000000005999}
}RIS
TY - JOUR TI - Imaging Proliferation of Stage IV Cutaneous Melanoma With 18 F-FLT PET/CT : A Potential Noninvasive Tool for Predicting Treatment Resistance to Targeted Therapy? AU - van der Hiel B AU - Vogel WV AU - van den Eertwegh AJM AU - Vlahu CA AU - de Vos FYFL AU - Boers-Sonderen MJ AU - Stokkel MPM AU - Aalbersberg EA AU - Haanen JBAG PY - 2025 JO - Clinical nuclear medicine DO - 10.1097/rlu.0000000000005999 UR - https://doi.org/10.1097/rlu.0000000000005999 ER -
APA
B, V. D. H., WV, V., AJM, V. D. E., CA, V., FYFL, D. V., MJ, B., MPM, S., EA, A., & JBAG, H. (2025). Imaging Proliferation of Stage IV Cutaneous Melanoma With 18 F-FLT PET/CT : A Potential Noninvasive Tool for Predicting Treatment Resistance to Targeted Therapy?. Clinical nuclear medicine. https://doi.org/10.1097/rlu.0000000000005999
Source records
- pubmed · retrieved 2026-09-26T09:47:09.334Z